Iambic's $2.5B IPO signals a new biotech era. Learn what drives premium valuations now, distinguishing true innovation from speculation.
Charles Taylor
·
72% of opinions are formed by packaging. Learn why startup brand refreshes boost customer acquisition by 10-20% and ROI by 3x.
·
AbbVie commits $1.2B to Iambic's AI platform for faster drug discovery. See how AI speeds up identifying new therapies, reducing time and cost.
·
Iambic's confidential S-1 filing offers insights for startups. See how this AI chip company prepares for a 2026 IPO and what it means for you.
·
What new AI products are coming in 2026? See how generative AI, predictive maintenance, and edge AI are shaping future tech. Reduced development by 30%.
·
·
5 min read
Rupt's new VP Sales faces a $1.2 trillion promotional tech market. Will AI and data-driven strategies help them win, or will competition prevail?
·
·
7 min read
Wingard's new B2B digital framework: Can personalized interaction scale without fracturing operations? See how they plan to achieve ROI.
·
·
6 min read
AI boosts campaign ROI by 17% for 2026. See how AI reshapes customer journeys and targets consumers, increasing engagement and profit.
·
·
3 min read
Iambic uses AI to speed up drug discovery. Learn how their Iambic Engine and $150M funding are accelerating cancer drug IAM-H1 to trials.
·
·
6 min read
Syngenta faces a 25% talent shortage in biotech. Learn how it's changing recruitment to attract startup-minded specialists & what's next for ag-tech.
·
·
7 min read
